XML 24 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
STATEMENTS OF CASH FLOWS (UNAUDITED) (USD $)
 6 Months Ended
Mar. 31, 2013
Mar. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (3,023,617) $ (12,075,172)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 223,863 281,853
Issuance of common stock, warrants and options for services 155,022 243,708
Extension of options issued to employees 0 36,990
Employee option cost 1,523,349 1,261,060
Common stock contributed to 401 (k) plan 79,709 75,889
Impairment loss on abandonment of patents 10,651 21,334
Loss on retired equipment 3,844 4,065
(Gain)/loss on derivative instruments (6,284,462) 3,247,857
(Increase)/decrease in assets:    
Receivables 119,055 355,879
Deferred rent 274,569 301,837
Prepaid expenses 214,679 376,182
Inventory used for R&D and manufacturing 97,708 202,778
Increase/(decrease) in liabilities:    
Accounts payable (150,880) (30,862)
Accrued expenses 40,084 (99,019)
Due to employees 42,702 (369)
Deferred rent liability 664 (2,759)
Deferred revenue 45 1,500
Deposits held 0 5,000
Net cash used in operating activities (6,673,015) (5,792,249)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of equipment (76,835) (30,810)
Expenditures for Patent costs (10,136) (50,480)
Net cash used in investing activities (86,971) (81,290)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of common stock 9,807,375 9,166,800
Proceeds from exercise of warrants and stock options 0 2,664,539
Payments on convertible debt 0 (4,950,000)
Payments on oblgations under capital leases (2,694) 0
Net cash provided by financing activities 9,804,681 6,881,339
NET INCREASE IN CASH AND CASH EQUIVALENTS 3,044,695 1,007,800
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 3,941,042 4,260,594
CASH AND CASH EQUIVALENTS, END OF PERIOD 6,985,737 5,268,394
ISSUANCE OF WARRANTS:    
Increase in derivative liabilities (4,200,000) (4,546,667)
Decrease in additional paid-in capital 4,200,000 4,546,667
Total 0 0
ISSUANCE OF ADDITIONAL SHARES    
Increase in common stock 0 (8,333)
Increase in additional paid-in capital 0 (241,667)
Decrease in additional paid-in capital 0 250,000
Total 0 0
EXERCISE OF DERIVATIVE LIABILITIES:    
Decrease in derivative liabilities 0 122,367
Increase in additional paid-in capital 0 (122,367)
Total 0 0
MODIFICATION OF WARRANTS:    
Increase additional paid-in capital 0 (325,620)
Decrease in additional paid-in capital 0 325,620
Total 0 0
INDUCEMENT WARRANTS:    
Increase in additional paid-in capital 0 (1,593,000)
Decrease in additional paid-in capital 0 1,593,000
Total 0 0
ISSUANCE OF COMMON STOCK FOR PREPAID SERVICES:    
Increase in additional paid-in capital (176,628) (213,333)
Increase in prepaid expenses 176,628 213,333
Total 0 0
Increase in patent costs 9,890 0
Increase in accounts payable (9,890) 0
Total 0 0
NON CASH RESEARCH AND OFFICE EQUIPMENT PURCHASES    
Increase in research and office equipment 49,413 0
Increase in accounts payable (12,791) 0
Increase in capital lease obligation (36,622) 0
Total 0 0
CAPITAL LEASE PAYMENTS INCLUDED IN ACCOUNTS PAYABLE:    
Decrease in capital lease obligation 1,150 0
Increase in accounts payable (1,150) 0
Total 0 0
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:    
Cash expenditures for interest expense $ 84,210 $ 294,910